Please, change device orientation to portrait

resources

Healthcare | Whitepaper

RX in Chains

The Drug Supply Chain Security Act (DSCSA) established an electronic and interoperable system to identify and trace prescription medications as they were distributed across the United States. The Food and Drug Administration (FDA) established a 10-year, three-phase plan for implementation, and a 100 percent compliance deadline by 2023.

As of last year, anti-counterfeit U.S. Customs and Border Protection (CBP) officials reported that 78,000 packages of illegal counterfeits were seized at John F. Kennedy Airport per day. While law enforcement officials continue to ramp up anti-counterfeit measures, phase two of the DSCSA is in effect. Legal requirements for track-and-trace, product verification, and illegitimate drug notification require action now, not later.

Blockchain aligns perfectly with DSCSA measures. Learn how to bring your company into compliance.

Download the Full Version to Learn More

We need your permission to process your personal data.